Bo Zhu
- Immunology top 0.5%
- Immunotherapy and Immune Responses 30
- Immune Cell Function and Interaction 22
- Immune cells in cancer 17
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 37
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 13
- Cancer Genomics and Diagnostics 12
-
- Lung Cancer Treatments and Mutations 24
-
- Epigenetics and DNA Methylation 12
- Co-authors
- Yongsheng LiYuyong JiangHaixia LongQingzhu JiaDegao ChenTong XiangZhengtang ChenWenlei Zhuo
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bo Zhu
203 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Immunology 2.7k
- Oncology 3.3k
- Cancer Research 1.6k
- Critical Care and Intensive Care Medicine 358
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Bo Zhu
This map shows the geographic impact of Bo Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhu more than expected).
Fields of papers citing papers by Bo Zhu
This network shows the impact of papers produced by Bo Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhu. The network helps show where Bo Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 8 | |
| 8 | 2021 | 4 | |
| 9 | Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4 | 2020 | 6 |
| 10 | 2019 | 147 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 2 | |
| 13 | 2018 | 79 | |
| 14 | 2016 | 47 | |
| 15 | 2015 | 6 | |
| 16 | 2010 | 48 | |
| 17 | Cancer stem cell and tumor immunity | 2010 | 1 |
| 18 | 2010 | 6 | |
| 19 | 2008 | 90 | |
| 20 | Recent Progress in Origin and Evolution of Microsporidia | 2007 | 1 |
About Bo Zhu
Bo Zhu is a scholar working on Oncology, Immunology and Cancer Research, having authored 213 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Immunotherapy and Immune Responses (30 papers), Lung Cancer Treatments and Mutations (24 papers), Immune Cell Function and Interaction (22 papers), Immune cells in cancer (17 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer Genomics and Diagnostics (12 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (3.3k citations) and Cancer Research (1.6k citations). Bo Zhu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yongsheng Li, Yuyong Jiang, Haixia Long, Qingzhu Jia, Degao Chen, Tong Xiang, Zhengtang Chen, Wenlei Zhuo, Zhongjun Li and Xiaomei Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.